Fahed Al Marzooqi

Part of Mubadala Healthcare, G42 Healthcare is an Emirati company that uses advanced AI techniques and vast computing resources to accelerate the detection of COVID-19, conduct research into new vaccines and drug therapies, and map trends in the outbreak including virus mutations. The company is based in Masdar, United Arab Emirates. The company is committed to harnessing data and advanced medical technologies to unlock the potential of personalized and preventive care, while transforming the traditional healthcare ecosystem. G42 Healthcare established Biogenix Labs, the UAE's first COVID-19 accredited large-scale throughput laboratory, and facilitated the #4Humanity clinical trials, the world's first phase III trials for an inactivated vaccine against COVID-19. The company plans to conduct research and development on genomics, imaging and diagnostics, and digitization programs to support the health of future generations. The CEO of the company is Ashish Koshy. G42 Healthcare was acquired by Mubadala Healthcare on October 06, 2022.